These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 2945089)
21. A novel class of adenosine A3 receptor ligands. 2. Structure affinity profile of a series of isoquinoline and quinazoline compounds. van Muijlwijk-Koezen JE; Timmerman H; Link R; van der Goot H; Ijzerman AP J Med Chem; 1998 Oct; 41(21):3994-4000. PubMed ID: 9767637 [TBL] [Abstract][Full Text] [Related]
22. Probes for narcotic receptor-mediated phenomena. 25. Synthesis and evaluation of N-alkyl-substituted (alpha-piperazinylbenzyl)benzamides as novel, highly selective delta opioid receptor agonists. Katsura Y; Zhang X; Homma K; Rice KC; Calderon SN; Rothman RB; Yamamura HI; Davis P; Flippen-Anderson JL; Xu H; Becketts K; Foltz EJ; Porreca F J Med Chem; 1997 Aug; 40(18):2936-47. PubMed ID: 9288176 [TBL] [Abstract][Full Text] [Related]
23. The 1:1 inclusion compounds zolmitriptan-benzene and zolmitriptan-phenol. Swamy GY; Sridhar B; Ravikumar K; Krishnan H Acta Crystallogr C; 2007 Jul; 63(Pt 7):o437-40. PubMed ID: 17609581 [TBL] [Abstract][Full Text] [Related]
25. Conformation analysis of aspartame-based sweeteners by NMR spectroscopy, molecular dynamics simulations, and X-ray diffraction studies. De Capua A; Goodman M; Amino Y; Saviano M; Benedetti E Chembiochem; 2006 Feb; 7(2):377-87. PubMed ID: 16372303 [TBL] [Abstract][Full Text] [Related]
26. Remoxipride and raclopride differentially alter the activity of incertohypothalamic dopaminergic neurons. Eaton MJ; Tian Y; Lookingland KJ; Moore KE Neuropharmacology; 1992 Nov; 31(11):1121-6. PubMed ID: 1475021 [TBL] [Abstract][Full Text] [Related]
27. X-ray diffraction studies of enkephalins and opiates. Griffin JF; Smith GD NIDA Res Monogr; 1988; 87():41-59. PubMed ID: 2855098 [TBL] [Abstract][Full Text] [Related]
28. Unique binding characteristics of antipsychotic agents interacting with human dopamine D2A, D2B, and D3 receptors. Malmberg A; Jackson DM; Eriksson A; Mohell N Mol Pharmacol; 1993 May; 43(5):749-54. PubMed ID: 8099194 [TBL] [Abstract][Full Text] [Related]
29. Liquid chromatographic studies on the aqueous solution conformation of substituted benzamides related to remoxipride. Clark CR; Smith FT; Clark MR; Garcia-Roura LE J Chromatogr Sci; 1990 Mar; 28(3):93-6. PubMed ID: 1980276 [TBL] [Abstract][Full Text] [Related]
30. Non coded C alpha, alpha-disubstituted amino acids. X-ray diffraction analysis of a dipeptide containing (S)-alpha-methylserine. Pavone V; Di Blasio B; Lombardi A; Maglio O; Isernia C; Pedone C; Benedetti E; Altmann E; Mutter M Int J Pept Protein Res; 1993 Jan; 41(1):15-20. PubMed ID: 8436444 [TBL] [Abstract][Full Text] [Related]
31. Potential neuroleptic agents. 3. Chemistry and antidopaminergic properties of substituted 6-methoxysalicylamides. de Paulis T; Kumar Y; Johansson L; Rämsby S; Florvall L; Hall H; Angeby-Möller K; Ogren SO J Med Chem; 1985 Sep; 28(9):1263-9. PubMed ID: 4040977 [TBL] [Abstract][Full Text] [Related]
32. Aromatic and amine substituent effects on the apparent lipophilicities of N-[(2-pyrrolidinyl)methyl]-substituted benzamides. Schmidt DE; Votaw JR; Kessler RM; de Paulis T J Pharm Sci; 1994 Mar; 83(3):305-15. PubMed ID: 8207673 [TBL] [Abstract][Full Text] [Related]
33. Molecular structure of 3-(methoxycarbonyl) amino-beta-carboline, a selective antagonist of the sedative effects of diazepam. Dodd RH; Ouannès C; Chiaroni A; Riche C; Poissonnet G; Rossier J; Devaux G; Potier P Mol Pharmacol; 1987 Jan; 31(1):74-80. PubMed ID: 3027526 [TBL] [Abstract][Full Text] [Related]
34. Antidopaminergic effects of the stereoisomers of N-[(1-alkyl-2- pyrrolidinyl)methyl]-5-sulfamoylbenzamides and -2,3-dihydrobenzofuran-7-carboxamides. Murakami S; Marubayashi N; Fukuda T; Takehara S; Tahara T J Med Chem; 1991 Jan; 34(1):261-7. PubMed ID: 1825115 [TBL] [Abstract][Full Text] [Related]
35. Further definition of the D1 dopamine receptor pharmacophore: synthesis of trans-6,6a,7,8,9,13b-hexahydro-5H-benzo[d]naphth[2,1-b]azepines as rigid analogues of beta-phenyldopamine. Negash K; Nichols DE; Watts VJ; Mailman RB J Med Chem; 1997 Jul; 40(14):2140-7. PubMed ID: 9216832 [TBL] [Abstract][Full Text] [Related]
36. Correspondence analysis of protein kinase C (PKC) inhibition by bis-basic substituted benzamides. Gilbert J; Cheminant M; Bignon E; Pons M; Ojasoo T; Doré JC Drug Des Discov; 1998 Oct; 15(4):253-67. PubMed ID: 10546070 [TBL] [Abstract][Full Text] [Related]
37. Role of strong intramolecular N-H...N hydrogen bonds in determining the conformation of adenosine-receptor antagonists. Ferretti V; Pretto L; Tabrizi MA; Gilli P Acta Crystallogr B; 2006 Aug; 62(Pt 4):634-41. PubMed ID: 16840813 [TBL] [Abstract][Full Text] [Related]
38. [Structural study of substituted benzamides with antidopaminergic D-2 activity. Comparison with orthopramides with 5HT-3 antiserotoninergic profile]. Collin S J Pharm Belg; 1991; 46(1):55-66. PubMed ID: 1828834 [TBL] [Abstract][Full Text] [Related]
39. Synthesis and structure-affinity relationships of novel N-(1-ethyl-4-methylhexahydro-1,4-diazepin-6-yl)pyridine-3-carboxamides with potent serotonin 5-HT3 and dopamine D2 receptor antagonistic activity. Hirokawa Y; Fujiwara I; Suzuki K; Harada H; Yoshikawa T; Yoshida N; Kato S J Med Chem; 2003 Feb; 46(5):702-15. PubMed ID: 12593651 [TBL] [Abstract][Full Text] [Related]
40. Quinazolines and 1,4-benzodiazepines. 92. Conformational recognition of the receptor by 1,4-benzodiazepines. Blount JF; Fryer RI; Gilman NW; Todaro LJ Mol Pharmacol; 1983 Nov; 24(3):425-8. PubMed ID: 6314115 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]